|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Kessler P, Grabenbauer G, Leher A,
Bloch-Birkholz A, Vairaktaris E and Neukam FW: Neoadjuvant and
adjuvant therapy in patients with oral squamous cell carcinoma:
Long-term survival in a prospective, non-randomized study. Br J
Oral Maxillofac Surg. 46:1–5. 2008. View Article : Google Scholar
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
4
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
5
|
Sankaranarayanan R, Masuyer E, Swaminathan
R, Ferlay J and Whelan S: Head and neck cancer: a global
perspective on epidemiology and prognosis. Anticancer Res.
18:4779–4786. 1998.PubMed/NCBI
|
|
6
|
Lazarus P and Park JY: Metabolizing enzyme
genotype and risk for upper aerodigestive tract cancer. Oral Oncol.
36:421–431. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schwartz SM, Doody DR, Fitzgibbons ED,
Ricks S, Porter PL and Chen C: Oral squamous cell cancer risk in
relation to alcohol consumption and alcohol dehydrogenase-3
genotypes. Cancer Epidemiol Biomarkers Prev. 10:1137–1144.
2001.PubMed/NCBI
|
|
8
|
Ames BN and Gold LS: Endogenous mutagens
and the causes of aging and cancer. Mutat Res. 250:3–16. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rajaraman P, Hutchinson A, Rothman N, et
al: Oxidative response gene polymorphisms and risk of adult brain
tumors. Neuro Oncol. 10:709–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Korde SD, Basak A, Chaudhary M, Goyal M
and Vagga A: Enhanced nitrosative and oxidative stress with
decreased total antioxidant capacity in patients with oral
precancer and oral squamous cell carcinoma. Oncology. 80:382–389.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z,
He L and Shi Y: A partition-ligation-combination-subdivision EM
algorithm for haplotype inference with multiallelic markers: update
of the SHEsis (http://analysis.bio-xcnuri).
Cell Res. 19:519–523. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin WJ, Jiang RS, Wu SH, Chen FJ and Liu
SA: Smoking, alcohol, and betel quid and oral cancer: a prospective
cohort study. J Oncol. 2011:5259762011.PubMed/NCBI
|
|
13
|
Borgstahl GE, Parge HE, Hickey MJ, et al:
Human mitochondrial manganese superoxide dismutase polymorphic
variant Ile58Thr reduces activity by destabilizing the tetrameric
interface. Biochemistry. 35:4287–4297. 1996. View Article : Google Scholar
|
|
14
|
McCord JM and Fridovich I: Superoxide
dismutase: the first twenty years (1968–1988). Free Radic Biol Med.
5:363–369. 1988.PubMed/NCBI
|
|
15
|
Hubackova M, Vaclavikova R, Ehrlichova M,
et al: Association of superoxide dismutases and NAD(P)H quinone
oxidoreductases with prognosis of patients with breast carcinomas.
Int J Cancer. 130:338–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valko M, Leibfritz D, Moncol J, Cronin MT,
Mazur M and Telser J: Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem Cell Biol.
39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kurokawa H, Sakimoto M, Yamashita Y,
Murata T and Kajiyama M: Manganese superoxide dismutase (Mn-SOD)
correlates with prognosis of patients with oral squamous cell
carcinoma. Fukuoka Igaku Zasshi. 89:321–327. 1998.PubMed/NCBI
|
|
18
|
Terakado N, Shintani S, Nakahara Y, et al:
Expression of Cu, Zn-SOD, Mn-SOD and GST-pi in oral cancer treated
with preoperative radiation therapy. Oncol Rep. 7:1113–1117.
2000.PubMed/NCBI
|
|
19
|
Yang J, Lam EW, Hammad HM, Oberley TD and
Oberley LW: Antioxidant enzyme levels in oral squamous cell
carcinoma and normal human oral epithelium. J Oral Pathol Med.
31:71–77. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marklund SL: Extracellular superoxide
dismutase and other superoxide dismutase isoenzymes in tissues from
nine mammalian species. Biochem J. 222:649–655. 1984.PubMed/NCBI
|
|
21
|
Kinnula VL and Crapo JD: Superoxide
dismutases in malignant cells and human tumors. Free Radic Biol
Med. 36:718–744. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yi JF, Li YM, Liu T, et al: Mn-SOD and
CuZn-SOD polymorphisms and interactions with risk factors in
gastric cancer. World J Gastroenterol. 16:4738–4746. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wiener HW, Perry RT, Chen Z, Harrell LE
and Go RC: A polymorphism in SOD2 is associated with development of
Alzheimer’s disease. Genes Brain Behav. 6:770–775. 2007.PubMed/NCBI
|
|
24
|
Hakenewerth AM, Millikan RC, Rusyn I, et
al: Joint effects of alcohol consumption and polymorphisms in
alcohol and oxidative stress metabolism genes on risk of head and
neck cancer. Cancer Epidemiol Biomarkers Prev. 20:2438–2449. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jemal A: Global burden of cancer:
opportunities for prevention. Lancet. 380:1797–1799. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu T, Wu Y, Huang Y, et al: RNAi targeting
CXCR4 inhibits tumor growth through inducing cell cycle arrest and
apoptosis. Mol Ther. 20:398–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coleman MP, Rachet B, Woods LM, et al:
Trends and socioeconomic inequalities in cancer survival in England
and Wales up to 2001. Br J Cancer. 90:1367–1373. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Cao W, Xu Q and Chen WT: The
expression of EMP1 is downregulated in oral squamous cell carcinoma
and possibly associated with tumour metastasis. J Clin Pathol.
64:25–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Srinivas PR, Kramer BS and Srivastava S:
Trends in biomarker research for cancer detection. Lancet Oncol.
2:698–704. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishikawa M: Reactive oxygen species in
tumor metastasis. Cancer Lett. 266:53–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Erejuwa OO, Sulaiman SA and Ab Wahab MS:
Honey: a novel antioxidant. Molecules. 17:4400–4423. 2012.
View Article : Google Scholar
|
|
33
|
Tian C, Fang S, Du X and Jia C:
Association of the C47T polymorphism in SOD2 with diabetes mellitus
and diabetic microvascular complications: a meta-analysis.
Diabetologia. 54:803–811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martin RC, Li Y, Liu Q, et al: Manganese
superoxide dismutase V16A single-nucleotide polymorphism in the
mitochondrial targeting sequence is associated with reduced
enzymatic activity in cryopreserved human hepatocytes. DNA Cell
Biol. 28:3–7. 2009. View Article : Google Scholar
|
|
35
|
Sasabe E, Yang Z, Ohno S and Yamamoto T:
Reactive oxygen species produced by the knockdown of
manganese-superoxide dismutase up-regulate hypoxia-inducible
factor-1alpha expression in oral squamous cell carcinoma cells.
Free Radic Biol Med. 48:1321–1329. 2010. View Article : Google Scholar
|
|
36
|
Shimoda-Matsubayashi S, Matsumine H,
Kobayashi T, Nakagawa-Hattori Y, Shimizu Y and Mizuno Y: Structural
dimorphism in the mitochondrial targeting sequence in the human
manganese superoxide dismutase gene. A predictive evidence for
conformational change to influence mitochondrial transport and a
study of allelic association in Parkinson’s disease. Biochem
Biophys Res Commun. 226:561–565. 1996.PubMed/NCBI
|
|
37
|
Yao S, Barlow WE, Albain KS, et al:
Manganese superoxide dismutase polymorphism, treatment-related
toxicity and disease-free survival in SWOG 8897 clinical trial for
breast cancer. Breast Cancer Res Treat. 124:433–439. 2010.
View Article : Google Scholar
|
|
38
|
Xu Z, Zhu H, Luk JM, et al: Clinical
significance of SOD2 and GSTP1 gene polymorphisms in Chinese
patients with gastric cancer. Cancer. 118:5489–5496. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kang D, Lee KM, Park SK, et al: Functional
variant of manganese superoxide dismutase (SOD2 V16A) polymorphism
is associated with prostate cancer risk in the prostate, lung,
colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers
Prev. 16:1581–1586. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wheatley-Price P, Asomaning K, Reid A, et
al: Myeloperoxidase and superoxide dismutase polymorphisms are
associated with an increased risk of developing pancreatic
adenocarcinoma. Cancer. 112:1037–1042. 2008. View Article : Google Scholar
|
